GL1X · GenesisL1 explorer

MolNFT v1 · #165281 · protein

Crystal structures of fniii domain one and two of the human leucocyte common antigen-related protein, lar

6TPV · Receptor-type tyrosine-protein phosphatase F: “Crystal structures of fniii domain one and two of the human leucocyte common antigen-related protein, lar”. X-ray diffraction, 2 pockets (best druggability 0.58). MolNFT v1 #165281 on…

PDB
6TPV
Type
protein
Length
387 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Receptor-type tyrosine-protein phosphatase F
EC
3.1.3.48
UniProt
P10586
Pockets
2 · best druggability 0.58

Structure

x-ray diffraction · 2 distinct chains · 2% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReceptor-type tyrosine-protein phosphatase F (EC 3.1.3.48)protein1912% helix, 48% strandP10586
BReceptor-type tyrosine-protein phosphatase F (EC 3.1.3.48)protein1962% helix, 47% strandP10586

Ligands and binding sites

  • IMD · Imidazole · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13170.580.7736empty
21220.400.7521empty

Interfaces

1 interface between chains.

  • A–B · 259 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 6TPV · Crystal structures of FNIII domain one and two of the human leucocyte common… · the same entry in another collection · chain A against A, TM-score 1.00
  • P10586 · AlphaFold monomer V2.0 prediction for receptor-type tyrosine-protein phosphatase F… · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.